FDA approves Lundbeck's antidepressant Brintellix

(Reuters) - The U.S. Food and Drug Administration approved Lundbeck's antidepressant Brintellix to treat adults with major depressive disorder. The drug, which Lundbeck will co-market with Japanese partner Takeda Pharmaceutical Co Ltd, will be available in four doses. Brintellix, like other antidepressants, will carry a boxed warning alerting patients and doctors to an increased risk of suicidal thoughts and behavior in children, adolescents and young adults aged 18-24 during initial treatment. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/fda-approves-lundbecks-antidepressant-brintellix-222534049--finance.html